Advertisement
Advertisement

NPCE

NPCE logo

Neuropace, Inc. Common Stock

15.31
USD
Sponsored
-0.30
-1.90%
Jan 29, 16:00 UTC -5
Closed
exchange

After-Market

15.32

+0.01
+0.08%

NPCE Earnings Reports

Positive Surprise Ratio

NPCE beat 12 of 19 last estimates.

63%

Next Report

Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
$22.57M
/
-$0.21
Implied change from Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q1 25 (Revenue/ EPS)
+0.23%
/
--

Neuropace, Inc. Common Stock earnings per share and revenue

On Jan 13, 2026, NPCE reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.15 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 25.46 million, with a --% difference. The market reacted with a +3.84% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 9 analysts forecast an EPS of -0.21 USD, with revenue projected to reach 22.57 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
logo
Intuitive Surgical Inc.
Report Date
Jan 22, 2026 For Q4 25
Estimate
$2.30
Actual
$2.52
Surprise
+9.86%
logo
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.63%
FAQ
For Q4 2025, Neuropace, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved up 3.84%, changed from $16.13 before the earnings release to $16.75 the day after.
The next earning report is scheduled for May 11, 2026.
Based on 9 analysts, Neuropace, Inc. Common Stock is expected to report EPS of -$0.21 and revenue of $22.57M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement